Smartphone Services for Stimulant Use Disorder

This study is testing two approaches to treating Stimulant Use Disorder, or problems with cocaine, crack, methamphetamine, etc. Stimulant Use Disorder is a national epidemic in the U.S. but there is no FDA-approved medication to treat it. There is a behavioral approach that has been found to be the most effective treatment for Stimulant Use Disorder, but this study is testing whether this can be delivered by a smartphone service, remotely, such as at home.

NCT Number	NCT07092059
Lead Sponsor	DynamiCare Health Collaborators: National Institute on Drug Abuse (NIDA)
Conditions	Stimulant Use Disorder
Enrollment	270 participants
Start Date	2025-06-24
Primary Completion	2027-05 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2025-07-29